JPS5585552A - New lactyltetrapeptide - Google Patents
New lactyltetrapeptideInfo
- Publication number
- JPS5585552A JPS5585552A JP14727579A JP14727579A JPS5585552A JP S5585552 A JPS5585552 A JP S5585552A JP 14727579 A JP14727579 A JP 14727579A JP 14727579 A JP14727579 A JP 14727579A JP S5585552 A JPS5585552 A JP S5585552A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- protected
- substance
- new
- give
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
NEW MATERIAL:Lactyl-alanyl-glutamyl-mesodiaminopimelyl-glycine I and its pharmaceutically permissible acid-addition salt. USE:An immune response accelerator, a reticulo-endothelial system exasperator, an interferon producer, a juvenescent substance, a phylaxis substance, a carcinostatic substance, etc. PROCESS:A compound II (R<4> is protected OH; R<5> is OH-protecting goup) is reacted with a compound III [R<1> is (protected) OH or (protected) hydrazino; R<2a> is NH2- protecting group; R<3> is (protected) OH] to give the compound I-1. The reaction is carried out in a solvent in the presence of a condensing agent. The protecting group of the product is removed by e.g. reduction, hydrolysis, etc., to give the compound I. The compound I can be also obtained by culturing streptomyces in the fermentation method. Some of the compounds II and III are new compounds.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7844364A GB2007791B (en) | 1977-11-16 | 1978-11-14 | Pipe fitting |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5585552A true JPS5585552A (en) | 1980-06-27 |
JPS6318598B2 JPS6318598B2 (en) | 1988-04-19 |
Family
ID=10501025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14727579A Granted JPS5585552A (en) | 1978-11-14 | 1979-11-14 | New lactyltetrapeptide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5585552A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57108050A (en) * | 1980-11-11 | 1982-07-05 | Fujisawa Pharmaceut Co Ltd | Novel peptide and its preparation |
JPS57114556A (en) * | 1980-10-27 | 1982-07-16 | Fujisawa Pharmaceut Co Ltd | Novel peptide compound and its preparation |
JPS57136555A (en) * | 1980-12-31 | 1982-08-23 | Fujisawa Pharmaceut Co Ltd | Novel peptide and its preparation |
JPS57140751A (en) * | 1981-01-29 | 1982-08-31 | Fujisawa Pharmaceut Co Ltd | Novel peptide, its preparation and use |
JPS57145845A (en) * | 1981-01-29 | 1982-09-09 | Fujisawa Pharmaceut Co Ltd | Novel peptide and its preparation |
DE3440621A1 (en) * | 1983-11-10 | 1985-05-23 | Fujisawa Pharmaceutical Co., Ltd., Osaka | PHARMACEUTICAL COMPOSITION FOR CONTROLLING VIRUS INFECTIONS AND THEIR USE |
JP2002539186A (en) * | 1999-03-17 | 2002-11-19 | ノボ ノルディスク アクティーゼルスカブ | Acylation method of peptide and novel acylating agent |
US9562910B2 (en) | 2002-09-25 | 2017-02-07 | Novo Nordisk A/S | Method for producing acylated peptides |
-
1979
- 1979-11-14 JP JP14727579A patent/JPS5585552A/en active Granted
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57114556A (en) * | 1980-10-27 | 1982-07-16 | Fujisawa Pharmaceut Co Ltd | Novel peptide compound and its preparation |
JPH0325437B2 (en) * | 1980-10-27 | 1991-04-05 | Fujisawa Pharmaceutical Co | |
JPS57108050A (en) * | 1980-11-11 | 1982-07-05 | Fujisawa Pharmaceut Co Ltd | Novel peptide and its preparation |
JPS57136555A (en) * | 1980-12-31 | 1982-08-23 | Fujisawa Pharmaceut Co Ltd | Novel peptide and its preparation |
JPS57140751A (en) * | 1981-01-29 | 1982-08-31 | Fujisawa Pharmaceut Co Ltd | Novel peptide, its preparation and use |
JPS57145845A (en) * | 1981-01-29 | 1982-09-09 | Fujisawa Pharmaceut Co Ltd | Novel peptide and its preparation |
DE3440621A1 (en) * | 1983-11-10 | 1985-05-23 | Fujisawa Pharmaceutical Co., Ltd., Osaka | PHARMACEUTICAL COMPOSITION FOR CONTROLLING VIRUS INFECTIONS AND THEIR USE |
JP2002539186A (en) * | 1999-03-17 | 2002-11-19 | ノボ ノルディスク アクティーゼルスカブ | Acylation method of peptide and novel acylating agent |
JP4949557B2 (en) * | 1999-03-17 | 2012-06-13 | ノヴォ ノルディスク アー/エス | Peptide acylation method and novel acylating agent |
US9562910B2 (en) | 2002-09-25 | 2017-02-07 | Novo Nordisk A/S | Method for producing acylated peptides |
Also Published As
Publication number | Publication date |
---|---|
JPS6318598B2 (en) | 1988-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5585552A (en) | New lactyltetrapeptide | |
JPS57108072A (en) | Preparation of n-acylcarnosine | |
JPS5473193A (en) | Preparation of antibiotic substance c-15003p-4 | |
JPS54151985A (en) | Preparation of aminocarbostyril derivative | |
JPS55105699A (en) | 3',4'-dideoxykanamycin a and its 1-n-aminoalkanoyl derivative | |
JPS57114547A (en) | Anthracycline antibiotic substance and its preparation | |
JPS57129696A (en) | Preparation of n-long-chain acylamino acid by bacterium | |
JPS5463024A (en) | 3-(n-formyl-n-hydroxyamino)-2(r)-hydroxypropyl-phosphonic acid, its preparation, and its use | |
JPS54100316A (en) | Preparation of derivative of aminobutyric acid | |
JPS578796A (en) | Preparation of 3alpha,7alpha-dihydroxy-12-keto-5beta-cholanic acid and/or its salt | |
JPS5257127A (en) | Process for hexyne-3-ol-1 | |
JPS51127080A (en) | A process for preparing quisqualic acid. | |
JPS5452059A (en) | Synthesis of tobramycin | |
JPS5538323A (en) | Preparation of s6,5'-cyclouridine | |
JPS5524139A (en) | Optically active intermediate and its preparation | |
JPS5538301A (en) | New derivative of antibiotics fortimicin and its preparation | |
JPS54138574A (en) | 1,2,3,4-tetrahydroisoquinoline derivative | |
JPS5663973A (en) | Novel thiadiazol-5-ylthiol ester and its preparation | |
JPS54122286A (en) | Dibenzazepine-2-acetic acid derivative | |
JPS5549397A (en) | Preparation of 17alpha-methylsteroid | |
JPS578795A (en) | Preparation of 3-substituted-7alpha-hydroxy-12-keto-5beta-cholanic acid and/or its salt | |
JPS57176942A (en) | Antibiotic substance mycoplanecin c derivative and its preparation | |
JPS57159493A (en) | Preparation of optically active beta-(r or s)-aminoglutaric monoalkyl ester | |
JPS5553294A (en) | Novel ansamitocin derivative and its preparation | |
EP0081320A3 (en) | Preparation of acetic acid derivatives |